SunPharma Industries Ltd. New1
Transcript of SunPharma Industries Ltd. New1
-
7/27/2019 SunPharma Industries Ltd. New1
1/27
Group members - Group No.1
NAMES
KHUSHALI THAKORE
KHUSHALI JAIN
KHYATI PATEL
KONICA JAIN
KRUNAL MEHTA
ROLL NO.
10061
10062
10063
10064
10065
-
7/27/2019 SunPharma Industries Ltd. New1
2/27
-
7/27/2019 SunPharma Industries Ltd. New1
3/27
Introduction
-
7/27/2019 SunPharma Industries Ltd. New1
4/27
Creating Value, Continuously
1983
Began with5 products
1993
First Research CentreSPARC, Baroda
1994
IPO - Rs. 550 Mnraised
1995
First APIPlant Panoli
1997
$7.5Mn investedin Caraco
2004
USD 350mnFCCB raised
2007
Demergerof innovative
R&D to SPARC
The performance continues
2010
5 Key operatingsubsidiaries8,000+ Employees
Invested Rs. 17 billionin Research
More than 50% of sales from international markets
Sun Pharma Today
83 10
19 Manufacturing facilitiesin 4 Continents
PART OF
-
7/27/2019 SunPharma Industries Ltd. New1
5/27
Manufacturing LocationsPlants across four continents enables us to compete with a tight
handle on cost and time to market across the geographies
Jammu
Ahmednagar
Maduranthakam
BangladeshPlant
Sikkim Plant
Ameri
cas
Cranbury
Detroit
Bryan
Tennessee
Goinia(Brazil)
Iztapalapa(Mexico)
Tiszavasvari(Hungary)
Europe
API and Formulations API Formulations
Halol
Ankleshwar
Panoli
DadraSilvassa
Karkhadi
India
-
7/27/2019 SunPharma Industries Ltd. New1
6/27
Vision, mission & values
Vision : To brand register in major markets of the
world.
Mission :
To lead globally in pharma sector.
To strengthen the market share & focus oncustomers needs.
-
7/27/2019 SunPharma Industries Ltd. New1
7/27
REVENUE COMPOSITION
45%
30%12%
13%
India
Branded Generics
5 Year CAGR 22%
US Generics
5 Year CAGR 33%
APIs
5 Year CAGR 19%
International Branded
Generics (ex-US)
5 Year CAGR 43%
2009-10 Annual sales : Rs 40,761 million5 Year CAGR 26%
-
7/27/2019 SunPharma Industries Ltd. New1
8/27
PHARMACEUTICAL MARKET
GLOBAL SCENARIO
INDIAN PHARMA MARKET
-
7/27/2019 SunPharma Industries Ltd. New1
9/27
India Branded Generics :Strong Base
Market Share 3.7%
Leadership in chronic
segment;Top 3 in over 50% of
more than 500 brands
Neuro-Psychiatry
27%
Cardiology19%
Diabetology11%
Gastroenterology14%
Gynecology &
Urology- 7%
Musculo-Skeletal& Pain- 5%
Antiasthamatic &Antiallergic- 5%
Opthalmology- 4%Others8%
Therapywise Break-up
-
7/27/2019 SunPharma Industries Ltd. New1
10/27
Mergers & acquisitionsYear Acquisition Country Rationale
2009Caraco acquired some products ofForests Inwood business
US Increased generic product offerings
2008 Acquired Chattem Chemicals, Inc. Tennessee, US Import registration with DEA, API Plantapproved by DEA in Tennessee, US
2005 Assets of Able labs New Jersey, US Dosage form plant (NJ, US) and IP
2005 Formulation plant in Bryan Ohio, US Dosage form plant (Ohio, US)
2005 Acquired ICN Hungary Hungary API and dosage form plant (Hungary)
2004 Womens Health Brands US Brands in womens health (US)
2004 Merged Phlox Pharma Baroda, India API Plant
2000Merged Pradeep DrugCompany Ltd (PDCL)
Chennai, India API Plant
1999 Merged Milmet Labs India Ophthalmology brands
1998 Brands from Natco India Respiratory brands
1997 Acquired Caraco Detroit, US Dosage form Plant
1997Merged Tamilnadu DadhaPharmaceuticals Ltd (TDPL)
Chennai, IndiaGynecology and oncology brands; APIand dosage form plant
1996 Acquired MJ Pharma Halol, IndiaDosage form plant (now USFDAapproved)
1996 Acquired Gujarat Lyka Ankleshwar, India API plant
1996 Bulk Drug plant from Knoll Pharma Ahmednagar,India
API plant (now USFDA approved)
-
7/27/2019 SunPharma Industries Ltd. New1
11/27
Shareholding patternas on 31stjuly10
Mutual Funds 3%
Promoter and
Promoter
group
63%
Bodies Corporate 5%
Individuals and others 6%
Financial Inst / Banks 3%
FIIs / Foreign Banks
20%
-
7/27/2019 SunPharma Industries Ltd. New1
12/27
FINANCE
-
7/27/2019 SunPharma Industries Ltd. New1
13/27
-
7/27/2019 SunPharma Industries Ltd. New1
14/27
-
7/27/2019 SunPharma Industries Ltd. New1
15/27
-
7/27/2019 SunPharma Industries Ltd. New1
16/27
-
7/27/2019 SunPharma Industries Ltd. New1
17/27
SALES & PAT
0
10000
20000
30000
40000
50000
60000
70000
2005-2006 2006-2007 2007-2008 2008-2009 2009-2010
Figures
inmillion
Year
PAT
Sales
-
7/27/2019 SunPharma Industries Ltd. New1
18/27
Profit ratio & ROI
0%
10%
20%
30%
40%
50%
60%
2005-2006 2006-2007 2007-2008 2008-2009 2009-2010
Valuein
Percentage
Year
NPAT
ROI
-
7/27/2019 SunPharma Industries Ltd. New1
19/27
INVENTORY TURNOVER
0
1
2
3
4
5
6
7
8
2005-2006 2006-2007 2007-2008 2008-2009 2009-2010
N
o.oftimes
Year
InventoryTurnover
-
7/27/2019 SunPharma Industries Ltd. New1
20/27
DEBT-EQUITY RATIO
0
0.2
0.4
0.6
0.8
1
1.2
1.4
2005-2006 2006-2007 2007-2008 2008-2009 2009-2010
Value
Year
DebtEquity
-
7/27/2019 SunPharma Industries Ltd. New1
21/27
CURRENT RATIO
0
2
4
6
8
10
12
2005-2006 2006-2007 2007-2008 2008-2009 2009-2010
Value
Year
Current Ratio
-
7/27/2019 SunPharma Industries Ltd. New1
22/27
EARNINGS PER SHARE
0
10
20
30
40
50
60
70
80
90
100
2005-2006 2006-2007 2007-2008 2008-2009 2009-2010
Rs.
Year
-
7/27/2019 SunPharma Industries Ltd. New1
23/27
Reasons for growth
INDIAN HEALTH CARE OPPORTUNITY
CONCENTRATION OF CHRONIC
INTERNATIONAL MARKET
MERGERS AND ACQUISITIONS
-
7/27/2019 SunPharma Industries Ltd. New1
24/27
Research & Development
Generic R&D spend around 8% of net
sales
Strong research teams in generics,
finished dosage development, biological
support, chemistry
2 R&D centers with about 600 scientists
Mumbai
Balancingthe risk
Medium term
Drug delivery systems
Immediate term
ANDA, DMF, Products for India
Baroda
-
7/27/2019 SunPharma Industries Ltd. New1
25/27
Corporate Governance
Our philosophy on corporate governance
envisages working towards high levels of
transparency, accountability and consistent value
systems across all facets of operations
Committee chaired by Keki Mistry comprisesHasmukh Shah and
S. Mohanchand Dadha
Audit Committee
Accountability
Responsibilty
Fareness
Consistent Value
-
7/27/2019 SunPharma Industries Ltd. New1
26/27
Corporatesocial responsibilty
Environmental issues
Handle waste
Minimize environment contamination
Reducing pollution
-
7/27/2019 SunPharma Industries Ltd. New1
27/27
THANKYOU